Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
Join Mergr to view the latest updates and news from Palo Alto-based EW Healthcare Partners.
In the last 3 years, EW Healthcare Partners has invested in 3 companies.
EW Healthcare Partners’ most common sectors for investment are medical products (42%) and life science (29%). The Firm’s most common investment types include venture (63%) and growth capital (19%). In total, EW Healthcare Partners has invested in 17 US states and 6 different countries. Its largest (disclosed) acquisition occurred in 2012 when it acquired Bioventus for $118M.
In the last 3 years, EW Healthcare Partners has exited 5 companies. The Firm’s most common exit type is trade sale (58%). EW Healthcare Partners’ largest (disclosed) exit occurred in 2012 when it sold EUSA Pharma for $680M.
Join Mergr to view EW Healthcare Partners’ full profile and discover more large private equity firms just like it.
No obligation. Cancel anytime.